| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
2e-08 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
3e-07 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |
| mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-07 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-07 |
| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |